BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 23995067)

  • 1. Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.
    Flavahan WA; Wu Q; Hitomi M; Rahim N; Kim Y; Sloan AE; Weil RJ; Nakano I; Sarkaria JN; Stringer BW; Day BW; Li M; Lathia JD; Rich JN; Hjelmeland AB
    Nat Neurosci; 2013 Oct; 16(10):1373-82. PubMed ID: 23995067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Starvation favors glioma stem cells.
    Ilkhanizadeh S; Weiss WA
    Nat Neurosci; 2013 Oct; 16(10):1359-61. PubMed ID: 24067285
    [No Abstract]   [Full Text] [Related]  

  • 3. A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.
    Libby CJ; Gc S; Benavides GA; Fisher JL; Williford SE; Zhang S; Tran AN; Gordon ER; Jones AB; Tuy K; Flavahan W; Gordillo J; Long A; Cooper SJ; Lasseigne BN; Augelli-Szafran CE; Darley-Usmar V; Hjelmeland AB
    Cell Adh Migr; 2021 Dec; 15(1):101-115. PubMed ID: 33843470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain.
    Kuo MH; Chang WW; Yeh BW; Chu YS; Lee YC; Lee HT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment.
    Zhang HL; Wang MD; Zhou X; Qin CJ; Fu GB; Tang L; Wu H; Huang S; Zhao LH; Zeng M; Liu J; Cao D; Guo LN; Wang HY; Yan HX; Liu J
    Cancer Lett; 2017 Mar; 388():1-11. PubMed ID: 27894955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
    J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of murine xenograft models of brain tumors from primary human tissue for in vivo analysis of the brain tumor-initiating cell.
    Qazi M; Mann A; van Ommeren R; Venugopal C; McFarlane N; Vora P; Singh SK
    Methods Mol Biol; 2014; 1210():37-49. PubMed ID: 25173159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
    Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
    Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in Vitro.
    Landis CJ; Zhang S; Benavides GA; Scott SE; Li Y; Redmann M; Tran AN; Otamias A; Darley-Usmar V; Napierala M; Zhang J; Augelli-Szafran CE; Zhang W; Hjelmeland AB
    ACS Chem Biol; 2018 Aug; 13(8):2048-2057. PubMed ID: 29905460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity.
    Sarkar S; Poon CC; Mirzaei R; Rawji KS; Hader W; Bose P; Kelly J; Dunn JF; Yong VW
    Sci Rep; 2018 Oct; 8(1):15286. PubMed ID: 30327548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose transporter 3 in neuronal glucose metabolism: Health and diseases.
    Peng W; Tan C; Mo L; Jiang J; Zhou W; Du J; Zhou X; Liu X; Chen L
    Metabolism; 2021 Oct; 123():154869. PubMed ID: 34425073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Patient-Derived Xenograft Model Using Brain Tumor Stem Cell Systems to Study Cancer.
    Chokshi C; Dhillon M; McFarlane N; Venugopal C; Singh SK
    Methods Mol Biol; 2016; 1458():231-45. PubMed ID: 27581026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells.
    Choi SA; Lee JY; Kwon SE; Wang KC; Phi JH; Choi JW; Jin X; Lim JY; Kim H; Kim SK
    PLoS One; 2015; 10(6):e0129292. PubMed ID: 26076490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells.
    Seliger C; Rauer L; Wüster AL; Moeckel S; Leidgens V; Jachnik B; Ammer LM; Heckscher S; Dettmer K; Riemenschneider MJ; Oefner PJ; Proescholdt M; Vollmann-Zwerenz A; Hau P
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
    Shibuya K; Okada M; Suzuki S; Seino M; Seino S; Takeda H; Kitanaka C
    Oncotarget; 2015 Jan; 6(2):651-61. PubMed ID: 25528771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.
    Yu D; Khan OF; Suvà ML; Dong B; Panek WK; Xiao T; Wu M; Han Y; Ahmed AU; Balyasnikova IV; Zhang HF; Sun C; Langer R; Anderson DG; Lesniak MS
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6147-E6156. PubMed ID: 28696296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53.
    Fukaya R; Ohta S; Yaguchi T; Matsuzaki Y; Sugihara E; Okano H; Saya H; Kawakami Y; Kawase T; Yoshida K; Toda M
    Cancer Res; 2016 May; 76(9):2813-23. PubMed ID: 26980763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.